drugset / Trial / NCT01195805

The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables

NCT01195805

Completed 25 enrolled Regional Hospital Holstebro
RandomizedCrossoverTriple-blindTreatment

Summary

The investigators wish to study the effect of retaining potassium. The participants have essential hypertension. The test substances are Amiloride, Spironolactone and placebo. The participants will ingest tablets for 28 days before being examined. We will perform a 24 hours urine collection, 24-hours bloodpressure measurement, blood and urine samples and we also examine the patient using a SphygmoCor.

Timeline

Start
2010-08
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amiloride Small molecule Oral
Comparator Spironolactone Small molecule Oral